Activin receptor ligand traps in chronic kidney disease

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 100%
• Activin Receptor 100%
• Sotatercept 50%
• Chimeric Protein 50%
• Normal Human 50%
• Cancer Growth Factor 50%
• Activin Receptor 2 50%
• Luspatercept 50%
• Protein 25%
• Blood Clotting Factor 11 25%
• Myelodysplastic Syndrome 25%
• Thalassemia 25%

Medicine and Dentistry

• Chimeric Protein 50%
• Luspatercept 50%
• Cancer Growth Factor 50%
• Activin Receptor 2 50%
• Sotatercept 50%
• Precursor 25%
• Volunteer 25%
• Erythropoiesis 25%
• Myelodysplastic Syndrome 25%
• Multiple Myeloma 25%
• Factor XI 25%
• Ineffective Erythropoiesis 25%